Literature DB >> 27778347

Hippocampal GABAergic transmission: a new target for adenosine control of excitability.

Diogo M Rombo1,2, Joaquim A Ribeiro1,2, Ana M Sebastião1,2.   

Abstract

Physiological network functioning in the hippocampus is dependent on a balance between glutamatergic cell excitability and the activity of diverse local circuit neurons that release the inhibitory neurotransmitter γ-aminobutyric acid (GABA). Tuners of neuronal communication such as adenosine, an endogenous modulator of synapses, control hippocampal network operations by regulating excitability. Evidence has been recently accumulating on the influence of adenosine on different aspects of GABAergic transmission to shape hippocampal function. This review addresses how adenosine, through its high-affinity A1 (A1 R) and A2A receptors (A2A R), interferes with different GABA-mediated forms of inhibition in the hippocampus to regulate neuronal excitability. Adenosine-mediated modulation of phasic/tonic inhibitory transmission, of GABA transport mechanisms and its interference with other modulatory systems are discussed together with the putative implications for neuronal function in physiological and pathological conditions. This article is part of a mini review series: 'Synaptic Function and Dysfunction in Brain Diseases'.
© 2016 International Society for Neurochemistry.

Entities:  

Keywords:  GABAergic transmission; adenosine receptors; hippocampus; interneurons; neuronal excitability

Mesh:

Substances:

Year:  2016        PMID: 27778347     DOI: 10.1111/jnc.13872

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

Review 1.  Neurotransmitter changes after traumatic brain injury: an update for new treatment strategies.

Authors:  Jennifer L McGuire; Laura B Ngwenya; Robert E McCullumsmith
Journal:  Mol Psychiatry       Date:  2018-09-13       Impact factor: 15.992

2.  A maestro role of adenosine A2A receptors in GABAergic synapses stabilization during postnatal neuronal maturation.

Authors:  Ana M Sebastião
Journal:  Purinergic Signal       Date:  2022-02-04       Impact factor: 3.950

3.  δ-Subunit Containing GABAA Receptors Modulate Respiratory Networks.

Authors:  Gaspard Montandon; Haiying Wu; Hattie Liu; Michael T Vu; Beverley A Orser; Richard L Horner
Journal:  Sci Rep       Date:  2017-12-22       Impact factor: 4.379

4.  Cognitive impairment after traumatic brain injury is associated with reduced long-term depression of excitatory postsynaptic potential in the rat hippocampal dentate gyrus.

Authors:  Bao-Liang Zhang; Yue-Shan Fan; Ji-Wei Wang; Zi-Wei Zhou; Yin-Gang Wu; Meng-Chen Yang; Dong-Dong Sun; Jian-Ning Zhang
Journal:  Neural Regen Res       Date:  2018-10       Impact factor: 5.135

Review 5.  The Signaling Pathways Involved in the Anticonvulsive Effects of the Adenosine A1 Receptor.

Authors:  Jeroen Spanoghe; Lars E Larsen; Erine Craey; Simona Manzella; Annelies Van Dycke; Paul Boon; Robrecht Raedt
Journal:  Int J Mol Sci       Date:  2020-12-30       Impact factor: 5.923

Review 6.  Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets.

Authors:  Silvia Pasquini; Chiara Contri; Stefania Merighi; Stefania Gessi; Pier Andrea Borea; Katia Varani; Fabrizio Vincenzi
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

Review 7.  Role of Adenosine in Epilepsy and Seizures.

Authors:  Fabio C Tescarollo; Diogo M Rombo; Lindsay K DeLiberto; Denise E Fedele; Enmar Alharfoush; Ângelo R Tomé; Rodrigo A Cunha; Ana M Sebastião; Detlev Boison
Journal:  J Caffeine Adenosine Res       Date:  2020-06-04

8.  Expression of functional inhibitory neurotransmitter transporters GlyT1, GAT-1, and GAT-3 by astrocytes of inferior colliculus and hippocampus.

Authors:  Elsa Ghirardini; Simon L Wadle; Vanessa Augustin; Jasmin Becker; Sina Brill; Julia Hammerich; Gerald Seifert; Jonathan Stephan
Journal:  Mol Brain       Date:  2018-01-25       Impact factor: 4.041

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.